✦ LIBER ✦

Overdosage of antidepressants: Clinical and pharmacokinetic aspects

✍ Scribed by O. L. Pedersen; L. F. Gram; C. B. Kristensen; M. Møller; P. Thayssen; M. Bjerre; P. Kragh-Sørensen; N. A. Klitgaard; E. Sindrup; P. Hole; M. Brinkløv

Publisher: Springer
Year: 1982
Tongue: English
Weight: 960 KB
Volume: 23
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00637499

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ANTIDEPRESSANTS: CLINICAL ASPECTS

✍ BURROWS, GRAHAM D. ;NORMAN, TREVOR 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

Several new agents for the treatment of depression have been introduced in recent years. While there are certain advantages for these agents over existing drugs, their ecacy and speed of onset of action is not dierent. The ecacy, adverse eects and toxicity of the various classes of antidepressants i

P16 Homicidal and suicidal overdosage of

P16 Homicidal and suicidal overdosage of insulin in ten patients — Clinical course, pharmacokinetics, epidemiology and forensic aspects

✍ M. Muhm; A. Berzlanovich; M. Müllner; D. Seidler; H.G. Stühlinger; G. Bauer; A.N 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Acute trichloroethylene poisoning by ing

Acute trichloroethylene poisoning by ingestion: Clinical and pharmacokinetic aspects

✍ L. Perbellini; D. Olivato; A. Zedde; R. Miglioranzi 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 217 KB

Clinical and pharmacokinetic aspects of

Clinical and pharmacokinetic aspects of the combination of meperidine and prilocaine for spinal anaesthesia

✍ Patrick Tauzin-Fin; Pierre Maurette; Gerard Vincon; Denise Hecquet; Marie-Christ 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 French ⚖ 510 KB

Adriamycin and methyl-CCNU combination t

Adriamycin and methyl-CCNU combination therapy in hepatocellular carcinoma: Clinical and pharmacokinetic aspects

✍ Rowan T. Chlebowski; Kenneth K. Chan; Myron J. Tong; John M. Weiner; Victor M. J 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 757 KB

Pharmacokinetic aspects of biotechnology

Pharmacokinetic aspects of biotechnology products

✍ Lisa Tang; Adam M. Persky; Günther Hochhaus; Bernd Meibohm 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB

In recent years, biotechnologically derived peptide and protein-based drugs have developed into mainstream therapeutic agents. Peptide and protein drugs now constitute a substantial portion of the compounds under preclinical and clinical development in the global pharmaceutical industry. Pharmacokin